Epstein-Barr virus-related antibody Changes titers therapy nasopharyngeal carcinoma long-term follow-up data prospective collaborative study North American patients significance various serologic tests antibody Epstein-Barr virus outcome treatment patients nasopharyngeal carcinoma patients repeated measurements titer various times diagnosis treatment associations trends titers slope log titer time level mean log titer outcome alive evidence disease alive recurrence nasopharyngeal carcinoma posttreatment sequential measurements outcome 